Table 1 Patient clinical and pathological characteristics.

From: Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication

Pt ID

Age

Sex

Therapya

Rai stage

ZAP-70

IGHV

Cytogenetic abnormalities

Ibrutinib resistance

BTK mutation

Proliferating fraction in untreated control

CCLL011

42

M

T

1

Pos

UM

Trisomy 12

No

No

2.7

CCLL015

56

F

T

1

Pos

UM

Trisomy 12

No

No

36.2

CCLL094

62

F

NT

1

Neg

M

del(13q14.3)

No

No

21.8

CCLL189

60

M

T

4

UM

del(13q14.3), del(11q22.3)

No

No

60.8

CCLL248

67

F

NT

3

Neg

M

del(13q14.3)

No

No

19.3

CCLL292

77

F

T

4

Neg

UM

del(13q14.3), del(17p)

No

No

31.3

CCLL306

68

M

T

3

Pos

UM

Normal

No

No

20.0

CCLL320

65

F

NT

4

N/A

UM

Normal

No

No

15.9

FCLL003

85

F

T

N/A

N/A

UM

Normal

No

No

62.5

FCLL008

65

F

T

3

N/A

UM

Complex, del(11q22.3), del(13q14.3)

No

No

66.5

FCLL009

87

F

T

1

N/A

UM

Complex, del(11q22.3), del(13q14.3)

No

No

89.7

FCLL012

61

M

NT

0

N/A

N/A

del(11q22.3), del(13q14.3)

No

No

44.4

FCLL016

56

M

NT

1

N/A

M

del(13q14.3)

No

No

87.0

FCLL018

65

M

NT

0

N/A

N/A

del(13q)

No

No

3.1

FCLL020

74

M

NT

1

Neg

M

del(13q14.3)

No

No

4.8

SCLL025

53

M

NT

2

Pos

UM

Normal

No

No

18.5

SCLL034

67

M

NT

0

Pos

M

Normal

No

No

55.6

UCLL040

77

M

T

0

Pos

N/A

del(11q22.3), trisomy 12

No

No

85.7

UCLL046

36

M

NT

1

N/A

M

Normal

No

No

70.8

UCLL047

64

M

NT

0

Neg

UM

Trisomy 12

No

No

83.1

UCLL053

45

M

NT

N/A

Ind

M

del(13q14.3)

No

No

51.5

UCLL057

88

F

T

3

N/A

UM

del(13q14.3)

No

No

4.9

UCLL058

40

M

T

2

Ind

UM

del(13q14.3)

No

No

6.2

NCLL018

47

M

T

2

Pos

UM

del(11q22.3), del(13q14.3)

Yes

BTKC481S

82.9

NCLL021

72

M

T

0

N/A

UM

Trisomy 12

Yes

No

92.1

UCLL011

57

F

T

N/A

Pos

UM

del(17p)

Yes

BTKC481S

65.8

UCLL017

68

M

T

N/A

Pos

UM

del(17p)

Yes

No

15.3

UCLL034

50

M

T

4

Pos

UM

del(13q14.3)

Yes

BTKC481Y

85.7

UCLL035

64

M

T

2

Pos

UM

del(11q22.3), del(13q14.3)

Yes

BTKC481S/Y

87.9

UCLL041

59

M

T

N/A

Neg

UM

del(17p)

Yes

BTKC481F

43.1

UCLL052

56

M

T

N/A

N/A

N/A

del(17p)

Yes

BTKC481S

87.3

  1. N/A information not available, Ind indeterminant, T treated, NT not treated.
  2. aTreatment status at the time of sample collection.